Navigating 11 Analyst Ratings For Bicycle Therapeutics
Navigating 11 Analyst Ratings For Bicycle Therapeutics
导航bicycle therapeutics的11个分析师评级
The standing of Bicycle Therapeutics among financial experts is...Analysts' ratings for Bicycle Therapeutics (NASDAQ:BCYC) over the last quarter vary from bullish to bearish, as provided by 11 analysts.
过去一个季度，11位分析师对Bicycle Therapeutics（纳斯达克：BCYC）的评级从看好到看淡不一。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $41.82, a high estimate of $55.00, and a low estimate of $28.00. Observing a downward trend, the current average is 2.74% lower than the prior average price target of $43.00.
分析师12个月目标价显示，平均目标为41.82美元，最高估值55.00美元，最低估值28.00美元。观察到下降趋势，当前平均价比之前43.00美元的平均目标价低2.74%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探讨分析师评级：分析师评级的深度探讨
The standing of Bicycle Therapeutics among financial experts is...
通过对近期分析师行...
登录免费看全文
登录/注册
资讯热榜
更新时间